Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Wall Street
Price Targets
DRREDDY Price Targets Summary
Dr Reddy's Laboratories Ltd
According to Wall Street analysts, the average 1-year price target for
DRREDDY
is 6 041.653 INR
with a low forecast of 3 954.15 INR and a high forecast of 7 124.25 INR.
Operating Income
Forecast
Operating Income Estimate
Dr Reddy's Laboratories Ltd
For the last 8 years the
compound annual growth rate for
Dr Reddy's Laboratories Ltd's operating income is
9%.
The projected
CAGR
for the next 4 years is
9%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DRREDDY's stock price target?
Price Target
6 041.653
INR
According to Wall Street analysts, the average 1-year price target for
DRREDDY
is 6 041.653 INR
with a low forecast of 3 954.15 INR and a high forecast of 7 124.25 INR.
What is Dr Reddy's Laboratories Ltd's Revenue forecast?
Projected CAGR
9%
For the last 8 years the
compound annual growth rate for
Dr Reddy's Laboratories Ltd's revenue is
6%.
The projected
CAGR
for the next 4 years is
9%.
What is Dr Reddy's Laboratories Ltd's Operating Income forecast?
Projected CAGR
9%
For the last 8 years the
compound annual growth rate for
Dr Reddy's Laboratories Ltd's operating income is
9%.
The projected
CAGR
for the next 4 years is
9%.
What is Dr Reddy's Laboratories Ltd's Net Income forecast?
Projected CAGR
7%
For the last 8 years the
compound annual growth rate for
Dr Reddy's Laboratories Ltd's net income is
9%.
The projected
CAGR
for the next 4 years is
7%.
You don't have any saved screeners yet
